Oncolytic vesicular stomatitis virus-based cellular vaccine improves triple-negative breast cancer outcome by enhancing natural killer and CD8+ T-cell functionality

J Immunother Cancer. 2020 Mar;8(1):e000465. doi: 10.1136/jitc-2019-000465.
No abstract available

Keywords: breast neoplasms; immunogenicity, vaccine; oncolytic virotherapy; tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD8-Positive T-Lymphocytes / immunology*
  • Female
  • Humans
  • Killer Cells, Natural / immunology*
  • Oncolytic Viruses / immunology*
  • Treatment Outcome
  • Triple Negative Breast Neoplasms / immunology*
  • Triple Negative Breast Neoplasms / pathology
  • Tumor Microenvironment
  • Vesicular Stomatitis / immunology*

Grants and funding